Odomzo®, sonidegib, is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC)
who are not amenable to curative surgery or radiation therapy
The normal growth of cells is controlled by various chemical signals. In patients with basal cell carcinoma, changes occur to genes controlling a part of this process known as the “hedgehog pathway”. This switches on signals that make the cancer cells grow out of control. Odomzo works by blocking this process, stopping cancer cells from growing and making new cells.
